Barnes-Jewish Extended Care receives four out of five stars
Barnes-Jewish Extended Care is a skilled nursing facility offering long-term care and sub-acute and rehabilitative services. It is supported by the resources of Barnes-Jewish Hospital and Washington University physicians. More than 1,000 individuals receive services at Barnes-Jewish Extended Care each year.
Read More ►
Barnes-Jewish Extended Care accepts admissions from most area hospitals but the majority come from Barnes-Jewish Hospital with a variety of diagnoses, including orthopedic, cardiac, pulmonary, neurological and general medicine. Barnes-Jewish Extended Care also works cooperatively with other BJC hospitals to reduce sub-acute admissions to the hospital.
Barnes-Jewish Extended Care continues to receive an above average ranking of four out of five stars from the Centers for Medicare and Medicaid. This is an accomplishment considering Barnes-Jewish Extended Care accepts the highest acuity patients in the St. Louis skilled nursing facility market. Accomplishments in 2014 include:
- An improvement from two stars to four in the quality indicator.
- Residents receiving short-term care with moderate to severe pain were 9.1 percent; the state average is 19.1 percent and the national average is 18.8 percent.
- Reduced use of anti-psychotic medications with 1.6 percent of Barnes-Jewish Extended Care residents receiving anti-psychotics; the state average is 3 percent and the national average is 2.7 percent.
- The implementation of a revised weight taking and weight review process involving a collaborative approach between the dietitian, therapy and nursing.
- A new incident reporting system to study trends in falls and to implement interventions to prevent new or repeat falls. Falls at Barnes-Jewish Extended Care were 31.6 percent versus the state average of 49.9 percent and the national average of 44.3 percent.
- A ranking of five stars for staffing due to the acuity of patients served at Barnes-Jewish Extended Care, and licensed nurse hours per patient day is four hours versus 1:22 in the state and 1:40 nationally.
Additional clinical achievements include:
- 96 percent compliance with hand hygiene.
- Improved response time for call lights from 7.8 minutes to 5.2 minutes.
- In collaboration with Barnes-Jewish Hospital and BJC HealthCare, reduction of hospitalizations by 8.5 percent, including a 20 percent reduction in patients with congestive heart failure.
Caregiver of the Year
Barnes-Jewish Hospital Rehabilitation Supervisor Coleen Carroll received a 2014 VOYCE Caregiver of the Year Award. VOYCE is a Missouri ombudsman resident advocacy program. The award recognizes long-term care staff and volunteers who demonstrate excellence in person-centered care. Winners were chosen from more than 300 long-term care communities as well as home care providers, hospice agencies and adult day programs in a 21-county service area.
Campus renewal project combines patient, family-centered design within environment of medical discovery
For nearly two years, clinicians, staff, patients and families worked hand-in-hand with the Washington University Medical Center Campus Renewal design team to transform the future of health care at Barnes-Jewish Hospital and St. Louis Children's Hospital.
Read More ►
Watch the campus renewal video
The Campus Renewal vision — to create patient- and family-centered facilities designed to provide safe and efficient care; a calm, comfortable environment that promotes healing; clear destinations; and an environment that fosters medical discovery through teamwork — continues to inform every decision, from patient room and lobby design to parking and landscaping.
S. Lee Kling Center for Proton Therapy completes first year of patient care
More than 100 cancer patients have received an innovative form of radiation therapy at the S. Lee Kling Center for Proton Therapy in the center's first year of operation.
Read More ►
The treatments, which utilize the world's first proton system of its kind, are provided at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis.
Proton therapy is a precise form of radiation that targets tumors while sparing surrounding healthy tissues, making it ideal for treating pediatric cancer patients, as well as adults with tumors near the heart, brain or in other sensitive locations. The new technology delivers the same targeted, noninvasive treatments as conventional proton systems but is considerably smaller in size and costs less.
"We offer proton therapy to patients we think would benefit from this particular technology, such as children and those with tumors in the brain or around the spinal cord," said Jeffrey Bradley, MD, a Washington University radiation oncologist and director of the S. Lee Kling Center for Proton Therapy. "We offer a full suite of cancer treatments, and this technology helps to meet the health-care needs of the patients we serve."
Since December 2013, the new system has:
- Delivered more than 6,700 clinical proton treatment fields to 118 patients. (One treatment field equals the use of a single proton beam. Each patient receives two or three treatment fields per therapy session.) Of those patients, about 25 percent were children and 75 percent were adults;
- Addressed a variety of complex tumors. Of adult tumors treated, 43 percent were in the brain, 27 percent were in the lungs, 11 percent were in the prostate and 8 percent were in the esophagus; and
- Treated more than 20 patients in a single day.
Lawrence Barry, 62, of St. Louis, recently finished proton therapy treatments at Siteman for a rare brain tumor. The tumor had been causing severe headaches and memory loss until it was surgically removed. His lead physician, Washington University radiation oncologist Clifford Robinson, MD, recommended proton therapy instead of X-ray radiation as a follow-up treatment.
"For every patient, we make a thoughtful decision about whether proton therapy is the best option," said Robinson, an assistant professor of radiation oncology at Washington University. "In Mr. Barry's case, we decided to use protons because it would decrease substantially the radiation dose to his heart, lungs and bowels. In addition, proton therapy reduces the side effects sometimes caused by X-ray radiation, such as such as nausea, diarrhea and fatigue."
A superconducting synchrocyclotron proton accelerator is a key component of the proton therapy system. The relatively small size of the device allows it to fit in a single room that isn't much larger than a traditional radiation therapy room. The cost of this single-vault proton therapy system was about $25 million. That represents a fraction of the investment needed for traditional proton therapy systems, which typically are housed in football field-sized buildings and cost more than $150 million.
Littleton, Massachusetts-based Mevion Medical Systems developed and manufactured the technology, called the MEVION S250 Proton Therapy System. Radiation oncologists and physicists at Washington University worked with Mevion to develop and refine the proton therapy technology.
The proton therapy center was named after the late S. Lee Kling, a visionary St. Louisan who traveled to the East Coast to receive proton therapy for an eye tumor. Kling, a former chairman of The Foundation for Barnes-Jewish Hospital's board of directors, believed the therapy should be more accessible and available to patients in St. Louis. As a result, Kling, along with family and friends, established the S. Lee Kling chair in radiation oncology – held by Dr. Bradley – to help lead the proton center's development and to conduct research into the most effective ways to use this new technology.
The center serves the St. Louis region and the Midwest. The next closest location offering proton therapy is in the Chicago area, about 280 miles away.